Advertisement

Topics

Aerpio Pharmaceuticals to Present at the Cowen 38th Annual Health Care Conference

07:00 EST 6 Mar 2018 | Businesswire

Aerpio Pharmaceuticals, Inc.

Aerpio Pharmaceuticals, Inc. (OTCQB: ARPO), a biopharmaceutical company focused on advancing first-in-class treatments for ocular diseases, today announced that Chief Executive Officer, Stephen Hoffman, M.D., Ph.D., will present at the Cowen 38th Annual Health Care Conference on Monday, March 12, 2018 at 2:50 p.m. Eastern Time in Boston, MA. Dr. Hoffman will provide a corporate overview and business update.

The presentation will be webcast live and may be accessed by visiting Aerpio's website at http://ir.aerpio.com/.

About Aerpio Pharmaceuticals

Aerpio Pharmaceuticals, Inc. is a biopharmaceutical company focused on advancing first-in-class treatments for ocular diseases. The Company’s lead compound, AKB‐9778, is a small molecule activator of the Tie2 pathway and is in clinical development for the treatment of non-proliferative diabetic retinopathy. For more information please visit www.aerpio.com.

Investor:
Aerpio Pharmaceuticals, Inc.
Michael Rogers, CFO
513-985-1958

NEXT ARTICLE

More From BioPortfolio on "Aerpio Pharmaceuticals to Present at the Cowen 38th Annual Health Care Conference"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Biopharmaceuticals
Biopharmaceuticals are medical drugs produced using biotechnology. They include proteins (including antibodies), nucleic acids (DNA, RNA or antisense oligonucleotides) and living microorganisms like virus and bacteria where the virulance of viruses and b...

Diabetes
Diabetes is a lifelong condition that causes a person's blood sugar level to become too high. The two main types of diabetes are: type 1 diabetes type 2 diabetes In the UK, diabetes affects approximately 2.9 million people. There are a...